Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 25;29(9):1973.
doi: 10.3390/molecules29091973.

In Silico Analysis: Anti-Inflammatory and α-Glucosidase Inhibitory Activity of New α-Methylene-γ-Lactams

Affiliations

In Silico Analysis: Anti-Inflammatory and α-Glucosidase Inhibitory Activity of New α-Methylene-γ-Lactams

Alexis Hernández-Guadarrama et al. Molecules. .

Abstract

The research about α-methylene-γ-lactams is scarce; however, their synthesis has emerged in recent years mainly because they are isosters of α-methylene-γ-lactones. This last kind of compound is structurally most common in some natural products' nuclei, like sesquiterpene lactones that show biological activity such as anti-inflammatory, anticancer, antibacterial, etc., effects. In this work, seven α-methylene-γ-lactams were evaluated by their inflammation and α-glucosidase inhibition. Thus, compounds 3-methylene-4-phenylpyrrolidin-2-one (1), 3-methylene-4-(p-tolyl)pyrrolidin-2-one (2), 4-(4-chlorophenyl)-3-methylenepyrrolidin-2-one (3), 4-(2-chlorophenyl)-3-methylenepyrrolidin-2-one (4), 5-ethyl-3-methylene-4-phenylpyrrolidin-2-one (5), 5-ethyl-3-methylene-4-(p-tolyl)pyrrolidin-2-one (6) and 4-(4-chlorophenyl)-5-ethyl-3-methylenepyrrolidin-2-one (7) were evaluated via in vitro α-glucosidase assay at 1 mM concentration. From this analysis, 7 exerts the best inhibitory effect on α-glucosidase compared with the vehicle, but it shows a low potency compared with the reference drug at the same dose. On the other side, inflammation edema was induced using TPA (12-O-tetradecanoylphorbol 13-acetate) on mouse ears; compounds 1-7 were tested at 10 µg/ear dose. As a result, 1, 3, and 5 show a better inhibition than indomethacin, at the same doses. This is a preliminary report about the biological activity of these new α-methylene-γ-lactams.

Keywords: anti-inflammatory; α-glucosidase; α-methylene-γ-lactams.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
α-methylene-γ-lactams tested as α-glucosidases and inflammation inhibitors.
Figure 2
Figure 2
Percentage of edema inhibition of 1 (24.81 ± 1.11%), 2 (24.81 ± 7.56%), 3 (32.42 ± 5.97%), 4 (10.05 ± 1.06%), 5 (28.73 ± 1.71%), 6 (8.67 ± 0.79%), 7 (17.45 ± 5.21%), and Indomethacin (31.90 ± 0.06%). Dose: 10 µg/ear. Each group represents the mean ± SEM of n = 5, *** p < 0.05 vs. vehicle.
Figure 3
Figure 3
Inhibitory activity of 1 (33.91 ± 0.73%), 2 (28.80 ± 2.41%), 3 (30.31 ± 1.13%), 4 (29.37 ± 2.88%), 5 (38.88 ± 1.61%), 6 (36.36 ± 1.21%), 7 (50.68 ± 1.67%), and Acarbose (87.98 ± 1.86%) [1 mM] on α-glucosidase activity. Each group represents the mean ± SEM of n = 6, *** p < 0.05 vs. vehicle.

References

    1. Pan American Health Organization. [(accessed on 3 November 2023)]. Available online: https://www.paho.org/en/topics/diabetes.
    1. International Diabetes Federation . IDF Diabetes Atlas. 10th ed. International Diabetes Federation; Brussels, Belgium: 2021. [(accessed on 3 November 2023)]. Available online: https://www.diabetesatlas.org/en.
    1. World Health Organization. [(accessed on 3 November 2023)]. Available online: https://www.who.int/health-topics/diabetes#tab=tab_1.
    1. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011;11:98–107. doi: 10.1038/nri2925. - DOI - PubMed
    1. Tsalamandris S., Antonopoulos A.S., Oikonomou E., Papamikroulis G.-A., Vogiatzi G., Papaioannou S., Defteros S., Tousoulis D. The Role of Inflammationn in Diabetes: Current Concepts and Future Perspectives. Eur. Cardiol. 2019;14:50–59. doi: 10.15420/ecr.2018.33.1. - DOI - PMC - PubMed

MeSH terms